NCT07020169Recruiting
Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study
Artificial Intelligence-Driven 3D Kidney Model for Real-Time Augmented Reality and Surgical Navigation in Minimally Invasive (Robotic/Laparoscopic) Partial Nephrectomy: A Prospective Validation Study
Source: ClinicalTrials.gov · Last updated 13 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this study is to develop a real-time artificial intelligence-driven 3D kidney model to assist robotic or laparoscopic partial nephrectomy: • Can this AI-powered model optimize the workflow of partial nephrectomy and enhance surgical benefits?
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 232 (estimated)
- First submitted
- 24 May 2025
- Start date
- 1 May 2025
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- Shao Pengfei
- Diseases
- Kidney cancer
- NCT number
- NCT07020169
What you commit to
- Study type: Interventional
- Planned participants: 232
- From 1 May 2025 to the primary completion date, 1 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior systemic anticancer therapy (targeted agents/immunotherapy/chemotherapy) within 6 months
- Absolute surgical contraindications (e.g., ASA class ≥IV, uncontrolled coagulopathy)
- Postoperative adjuvant therapy during protocol-defined follow-up (12 months)
- Concurrent enrollment in interventional clinical trials
Lab values
- Major comorbidities (e.g., NYHA class III/IV heart failure, eGFR \<30 mL/min/1.73m²) affecting outcome assessment
Other
- Multifocal renal tumors (bilateral or unilateral)
- Intraoperative conversion to radical nephrectomy or open approach
- Investigator-determined ineligibility based on risk-benefit analysis
Who the study is looking for
- Ages 18-80 years, regardless of gender
- Written informed consent obtained from the patient or legally authorized representative after full protocol disclosure
- Preoperative imaging (CT/MRI) confirming clinical stage T1a or select T1b renal tumors suitable for partial nephrectomy (R.E.N.A.L. nephrometry score ≤10)
- Localized renal tumors without lymph node/distant metastasis per NCCN Guidelines® (v2023)
- Elective minimally invasive partial nephrectomy (laparoscopic/robotic) after comprehensive surgical counseling
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Coordinator of this site? Confirm its status | Nanjing | China | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.